Literature DB >> 8588244

Elucidating the mechanism of action of the immunosuppressant 15-deoxyspergualin.

S G Nadler1, A C Eversole, M A Tepper, J S Cleaveland.   

Abstract

15-Deoxyspergualin (DSG) is an immunosuppressive agent currently in Phase I/II clinical trials. We have previously shown that DSG specifically interacts with Hsc70, a member of the heat shock protein 70 family. In this article we show that DSG appears to bind either kinetically or to a different site on Hsc70 from that of peptides. In addition, we show that DSG inhibits the localization of Hsp70 into the nucleus in response to heat shock. Finally, data are presented showing that there is a correlation between decreases in the transcription factor nuclear factor kappa B and kappa light chain expression in response to varying doses of DSG.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8588244     DOI: 10.1097/00007691-199512000-00026

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  13 in total

Review 1.  Role of T cell-nuclear factor κB in transplantation.

Authors:  Luciana L Molinero; Maria-Luisa Alegre
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

Review 2.  Targeting Hsp70 facilitated protein quality control for treatment of polyglutamine diseases.

Authors:  Amanda K Davis; William B Pratt; Andrew P Lieberman; Yoichi Osawa
Journal:  Cell Mol Life Sci       Date:  2019-09-24       Impact factor: 9.261

Review 3.  STEALTH in transplantation tolerance.

Authors:  Anne Hutchings; William J Hubbard; Frank T Thomas; Judith M Thomas
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 4.  Chaperone proteins and brain tumors: potential targets and possible therapeutics.

Authors:  Michael W Graner; Darell D Bigner
Journal:  Neuro Oncol       Date:  2005-07       Impact factor: 12.300

Review 5.  Clinically significant drug interactions with new immunosuppressive agents.

Authors:  C Mignat
Journal:  Drug Saf       Date:  1997-04       Impact factor: 5.606

Review 6.  Protein chaperones: a composition of matter review (2008 - 2013).

Authors:  Tony Taldone; Hardik J Patel; Alexander Bolaender; Maulik R Patel; Gabriela Chiosis
Journal:  Expert Opin Ther Pat       Date:  2014-05       Impact factor: 6.674

Review 7.  Pharmacological targeting of the Hsp70 chaperone.

Authors:  Srikanth Patury; Yoshinari Miyata; Jason E Gestwicki
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

8.  Polyamine compound deoxyspergualin inhibits heat shock protein-induced activation of immature dendritic cells.

Authors:  Atsushi Sugawara; Toshihiko Torigoe; Yasuaki Tamura; Kenjiro Kamiguchi; Kyuichi Nemoto; Hiroshi Oguro; Noriyuki Sato
Journal:  Cell Stress Chaperones       Date:  2008-08-07       Impact factor: 3.667

9.  Deoxyspergualin, an immunosuppressant, in patients suffering from nephropathies with crescent formation: an open-label trial to evaluate safety and efficacy.

Authors:  Hirokazu Imai; Osamu Hotta; Mitsuhiro Yoshimura; Tsuneo Konta; Yoshiharu Tsubakihara; Masanobu Miyazaki; Chie Tomida; Masaki Kobayashi; Satoshi Suzuki; Hideo Shiiki; Atsushi Yamauchi; Hitoshi Yokoyama; Masato Nose
Journal:  Clin Exp Nephrol       Date:  2006-03       Impact factor: 2.801

10.  Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.

Authors:  Hanns-Martin Lorenz; Wilhelm H Schmitt; Vladimir Tesar; Ulf Müller-Ladner; Ingo Tarner; Ingeborg A Hauser; Falk Hiepe; Tobias Alexander; Heike Woehling; Kyuichi Nemoto; Peter A Heinzel
Journal:  Arthritis Res Ther       Date:  2011-03-01       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.